Sharaz Khan Head of Pathology Northampton General Hospital 💙 commenting on an independent health economic study showing @Digistain could save the NHS £287m #oncology #pathology #breastcancer #Cancer #metastaticbreastcancer digistain.co.uk/breast-cancer-…

Fantastic news for BIVDA member digistain 👏 Further evidence that innovative diagnostics not only save money, but improve patient outcomes too. #digistain #IVDs #innovation #breastcancer #diagnostics #AI

Apply to take part in The Show by Breast Cancer Now, the fashion show like no other. It’s more than a catwalk, more than just clothes. Our amazing models are all people living with or beyond breast cancer. breastcancernow.org/get-involved/s…

Independent study by Health Tech Enterprise outlining carbon footprint saving enabled by Digistain® novel approach. healthtechenterprise.co.uk/casestudies/ca… #breastcancer #netzero

CEO Hemmel Amrania commenting on an Independent health economic study showing @Digistain could save the NHS £287m digistain.co.uk/breast-cancer-… #oncology #pathology #breastcancer

🔈Congrats to the 30 start-ups that have been selected for the Catapult 2023-24 semi-finals! 🤝They will receive high-quality training from experienced entrepreneurs, investors and experts in the field, to strengthen their business plans and pitches. 👉loom.ly/-DNbqT8

Welcome to our new website digistain.co.uk

#BreastCancerAwarenessMonth

This is good. Thank you Leah Hardy x.com/LeahFHardy/sta…

Technology to overcome the time and cost challenges associated with traditional breast cancer recurrence risk testing. Find out more here digistain.co.uk #breastcancer #innovation

Personalised cancer decision-making at an industry transforming speed and price digistain.co.uk #breastcancer #oncology #pathology

How is our technology driving dramatically faster breast cancer risk recurrence profiling. This is how. lnkd.in/eVt2-Xrt #breastcancer #ai #innovation

Proud to support #BreastCancerAwarenessMonth

For us ‘hope’ as a strategy for cancer care was not an option. Read our story here digistain.co.uk/our-story/ #breastcancer #patients

Proud to support #BreastCancerAwarenessMonth

To all our supporters this year, all the patients & clinicians we have worked with, and the many we plan to help in the future… …we wish you all a wonderful festive season and a healthy happy 2024.

Complexly novel way to assess risk of recurrence in ER+/HER2- early breast cancer using mid-infrared spectrometer digistain It’s simple,quick & can be done locally. First data using Nottinghan series, shows it can separate patients into low vs high risk. More studies underway.

Our recently published validation of a novel and effective methodology to support therapy decisions in early breast cancer demonstrated e equivalent performance to existing solutions in over 800 patients. But radically faster and more accessible. link.springer.com/article/10.100…